How many institutions own PBM stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PBM shares is 3, representing 4.02% of the company's common stock.

Who are the major shareholders selling Psyence Biomedical Ltd. stock?

STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD, in the last quarter, reduced its stake in PBM by -100% restricting it's holding to 0 shares of worth nearly -. BANK OF AMERICA CORP /DE/ also lessened -100% of the PBM shares from its portfolio, reducing its holding to 0 shares of worth -. VIRTU FINANCIAL LLC also shunned PBM shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying PBM stock?

As per its latest 13F filing, CAITLIN JOHN, LLC increased its stake in PBM by 100% in the last quarter. The institutional holder raised its holding to 35 shares having worth more than $107.00. UBS GROUP AG also added 100% more shares of PBM to its portfolio, raising its holding to 60 shares of worth $184.00. CITADEL ADVISORS LLC also increased its PBM shares holding by 100% which brought its holding to 11.69 thousand shares worth $35.78K.

PBM's major insiders: who are they?

The insider with the most stakes in PBM is N/A , N/A at the company. Additionally, PBM stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell PBM stock?

Company executives, directors, and other insiders own 2.97% percent of Psyence Biomedical Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which PBM insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased PBM stock?

There have been 0 transaction(s) during the past 6-months in which Psyence Biomedical Ltd. insiders have bought stock, totalling 0 shares

How much of PBM does insiders own?

Around 0 Psyence Biomedical Ltd. shares are held by insiders, which represents about 2.97% of PBM stock.

Who is the insider with the largest stake?

PBM N/A, N/A holds the largest portfolio of the company's shares. PBM shares owned by N/A total nearly -.

Which institution holds the most shares in PBM?

PARALLEL ADVISORS, LLC is the largest institutional owner in PBM which holds 151.25 thousand shares worth $574.75K or 10.21% of the total PBM shares outstanding followed by CAITLIN JOHN, LLC with ownership of 35 shares representing 0% of the PBM ownership. UBS GROUP AG is the third largest stakeholder with 60 shares or 0% of the ownership worth more than $184.00.

Is Psyence Biomedical Ltd. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PBM is concerned, it is a stock which is not optionable.

Is there a short position on PBM's shares?

Number of PBM shares short is 30.72K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding PBM shares are there?

As of today, 3.81M shares of PBM are outstanding.

Is there many float in PBM stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PBM has 2.61M shares in float.

PBM short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PBM is 0.57.

Stock Ideas

PBM Stock Ownership Breakdown

NASDAQ : PBM

Psyence Biomedical

$4.97

0.13+2.69%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares0.81

Short Percent Of Float1.15

Shares Outstanding3.81M

Shares Float2.61M

Shares Short30.72K

Short Ratio0.57

1.15%

Short % of Float

0.81%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

2.97% Percentage of Shares held by All Insiders

4.02% Percentage of Shares held by All Institutions

4.14% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 4.02% of PBM shares are held by financial institutions. PARALLEL ADVISORS, LLC is the top corporate investor, holding 151.25K shares valued at $574.75K. A 10.21% stake in Psyence Biomedical Ltd. is owned by the company. CAITLIN JOHN, LLC owns 35 shares valued at $107.00, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2026	PARALLEL ADVISORS, LLC	10.21%	151.25K	574.75K	0	0
Jun 30, 2026	CAITLIN JOHN, LLC	0%	35	107	35	+100.00%
Jun 30, 2026	UBS GROUP AG	0%	60	184	60	+100.00%
Jun 30, 2026	STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD	0.01%	89	272	0	0
Jun 30, 2026	CITADEL ADVISORS LLC	0.79%	11.69K	35.78K	11.69K	+100.00%
Jun 30, 2026	XTX TOPCO LTD	1.02%	15.09K	46.19K	15.09K	+100.00%
Jun 30, 2026	JANE STREET GROUP, LLC	2.05%	30.43K	93.12K	30.43K	+100.00%
Jun 30, 2026	MORGAN STANLEY	2.55%	37.8K	115.68K	37.8K	+100.00%
Jun 30, 2026	ADVISORSHARES INVESTMENTS LLC	8.25%	122.18K	373.88K	122.18K	+100.00%
Mar 31, 2026	STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD	0%	0	-	-561	-100.00%
Mar 31, 2026	PARALLEL ADVISORS, LLC	10.21%	151.25K	574.75K	0	0
Mar 31, 2026	BANK OF AMERICA CORP /DE/	0%	0	-	-3.35K	-100.00%
Mar 31, 2026	VIRTU FINANCIAL LLC	0%	0	-	-37.04K	-100.00%
Mar 31, 2026	UBS GROUP AG	0%	0	-	-1.01K	-100.00%
Sep 30, 2024	CITADEL ADVISORS LLC	0.02%	169.25K	16.93K	169.25K	+100.00%
Sep 30, 2024	UBS GROUP AG	0%	15.03K	1.5K	-7.86K	-34.32%
Sep 30, 2024	MORGAN STANLEY	0%	48.41K	4.84K	28.41K	+142.04%
Sep 30, 2024	STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD	0.01%	80.5K	8.05K	80.5K	+100.00%
Sep 30, 2024	ADVISORSHARES INVESTMENTS LLC	0.12%	1.23M	123.24K	769.33K	+166.15%
Sep 30, 2024	JANE STREET GROUP, LLC	0%	45.96K	4.6K	45.96K	+100.00%
Sep 30, 2024	CANTOR FITZGERALD, L. P.	0.03%	337K	33.7K	0	0
Sep 30, 2024	GEODE CAPITAL MANAGEMENT, LLC	0%	10.49K	1.05K	0	0
Sep 30, 2024	HRT FINANCIAL LP	0%	25.77K	2K	7.69K	+42.53%
Sep 30, 2024	HEADLANDS TECHNOLOGIES LLC	0%	0	-	-25	-100.00%
Sep 30, 2024	JPMORGAN CHASE & CO	0%	0	-	-2	-100.00%
Sep 30, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0%	34.39K	3.44K	34.39K	+100.00%
Sep 30, 2024	VIRTU FINANCIAL LLC	0%	0	-	-14.9K	-100.00%
Sep 30, 2024	CLEAR STREET LLC	0%	0	-	-20K	-100.00%
Sep 30, 2024	TWO SIGMA SECURITIES, LLC	0%	14.99K	1.5K	14.99K	+100.00%

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.